Personalizing the approach to asthma treatment

References

• Holgate ST. Asthma: a simple concept but in reality a complex disease. Eur J Clin Invest. 2011 Dec;41(12):1339–1352.
   PubMed Web of Science ®Google Scholar
• Wenzel SE. Asthma phenotypes: the evolution from clinical to molecular approaches. Nat Med. 2012 May 4;18(5):716–725.
   PubMed Web of Science ®Google Scholar
• Global Initiative for Asthma (GINA) - 2017 GINA Report, Global Strategy for Asthma Management and Prevention. (cited 2017 Feb 20). Available from: http://ginasthma.org/2017-ginareport-global-strategy-for-asthma-management-and-prevention/
   Google Scholar
• Osterberg L, Blaschke T. Adherence to medication. N Engl J Med. 2005;353(5):487–497.
   PubMed Web of Science ®Google Scholar
• Braido F, Baiardini I, Sumberesi M, et al. Obstructive lung diseases and inhaler treatment: results from a national public pragmatic survey. Respir Res. 2013;14:94.
   PubMed Web of Science ®Google Scholar
• Virchow JC, Crompton GK, Dal Negro R, et al. Importance of inhaler devices in the management of airway disease. Respir Med. 2008;102:10–19.
   PubMed Web of Science ®Google Scholar
• Bresciani M, Paradis L, Des Roches A, et al. Rhinosinusitis in severe asthma. J Allergy Clin Immunol. 2001;107:73–80.
   PubMed Web of Science ®Google Scholar
• Umetsu DT. Mechanisms by which obesity impacts upon asthma. Thorax. 2017;72(2):174–177.
   PubMed Web of Science ®Google Scholar
• Ferrando M, Bagnasco D, Varricchi G, et al. Personalized medicine in allergy. Allergy Asthma Immunol Res. 2017 Jan;9(1):15–24.
   PubMed Web of Science ®Google Scholar
• Canonica GW, Ferrando M, Baiardini I, et al. Asthma: personalized and precision medicine. Curr Opin Allergy Clin Immunol. 2018 Feb;18(1):51–58.
   PubMed Web of Science ®Google Scholar
• Haldar P, Pavord ID, Shaw DE, et al. Cluster analysis and clinical asthma phenotypes. Am J Respir Crit Care Med. 2008 Aug 1;178(3):218–224.
   PubMed Web of Science ®Google Scholar
• Simpson JL, Scott R, Boyle MJ, et al. Inflammatory subtypes in asthma: assessment and identification using induced sputum. Respirology. 2006;11(1):54–61.
   PubMed Web of Science ®Google Scholar
• Tliba O, Panettieri RA Jr. Paucigranulocytic asthma: uncoupling of airway obstruction from inflammation. J Allergy Clin Immunol. 2018 Jun 19. pii: S0091–6749(18)30861–3. https://www.ncbi.nlm.nih.gov/pubmed/29928921.
   PubMedGoogle Scholar
• Trejo Bittar HE, Yousem SA, Wenzel SE. Pathobiology of severe asthma. Annu Rev Pathol. 2015;10:511–545.
   PubMed Web of Science ®Google Scholar
• Woodruff PG, Modrek B, Choy DF, et al. T-helper type 2-driven inflammation defines major subphenotypes of asthma. Am J Respir Crit Care Med. 2009 Sep 1;180(5):388–395.
   PubMed Web of Science ®Google Scholar
• Desai M, Oppenheimer J. Elucidating asthma phenotypes and endotypes: progress towards personalized medicine. Ann Allergy Asthma Immunol. 2016 May;116(5):394–401.
   PubMed Web of Science ®Google Scholar
• Heffler E, Berry M, Pavord ID. Tumor necrosis factor-alpha: a promising therapeutic target for asthma? BioDrugs. 2007;21(6):345–349.
   PubMed Web of Science ®Google Scholar
• Passalacqua G, Bagnasco D, Ferrando M, et al. Current insights in allergen immunotherapy. Ann Allergy Asthma Immunol. 2018 Feb;120(2):152–154.
   PubMed Web of Science ®Google Scholar
• Vijverberg SJ, Hilvering B, Raaijmakers JA, et al. Clinical utility of asthma biomarkers: from bench to bedside. Biologics. 2013;7:199–210.
   PubMedGoogle Scholar
• Chiang DT, Clark J, Casale TB. Omalizumab in asthma: approval and postapproval experience. Clin Rev Allergy Immunol. 2005 Aug;29(1):3–16.
   PubMed Web of Science ®Google Scholar
• Bagnasco D, Ferrando M, Varricchi G, et al. A critical evaluation of anti-IL-13 and Anti-IL-4 strategies in severe asthma. Int Arch Allergy Immunol. 2016;170(2):122–131.
   PubMed Web of Science ®Google Scholar
• Izuhara K, Ohta S, Ono J. Using periostin as a biomarker in the treatment of asthma. Allergy Asthma Immunol Res. 2016 Nov;8(6):491–498.
   PubMed Web of Science ®Google Scholar
• Ntontsi P, Papathanassiou E, Loukides S, et al. Targeted anti-IL-13 therapies in asthma: current data and future perspectives. Expert Opin Investig Drugs. 2018 Feb;27(2):179–186.
   PubMed Web of Science ®Google Scholar
• Wagener AH, de Nijs SB, Lutter R, et al. External validation of blood eosinophils, FE(NO) and serum periostin as surrogates for sputum eosinophils in asthma. Thorax. 2015;70(2):115–120.
   PubMed Web of Science ®Google Scholar
• Parulekar AD, Kao CC, Diamant Z, et al. Targeting the interleukin-4 and interleukin-13 pathways in severe asthma: current knowledge and future needs. Curr Opin Pulm Med. 2018;24(1):50–55.
   PubMed Web of Science ®Google Scholar
• US Food and Drug Administration (FDA). Approval of Alair bronchial thermoplasty system: Alair catheter and Alair RF controller. 2010. https://www.accessdata.fda.gov/cdrh_docs/pdf8/p080032a.pdf.
   Google Scholar
• Pavord ID, Cox G, Thomson NC, et al. Safety and efficacy of bronchial thermoplasty in symptomatic, severe asthma. Am J Respir Crit Care Med. 2007;176(12):1185–1191.
   PubMed Web of Science ®Google Scholar
• Casale TB, Bateman ED, Vandewalker M, et al. Tiotropium respimat add-on is efficacious in symptomatic asthma, independent of T2 phenotype. J Allergy Clin Immunol Pract. 2018 May - Jun;6(3):923–935.e9.
   PubMed Web of Science ®Google Scholar
• Gibson PG, Yang IA, Upham JW, et al. Effect of azithromycin on asthma exacerbations and quality of life in adults with persistent uncontrolled asthma (AMAZES): a randomised, double-blind, placebo-controlled trial. Lancet. 2017 Aug 12;390(10095):659–668.
   PubMed Web of Science ®Google Scholar
• Corren J, Parnes JR, Wang L, et al. Tezepelumab in adults with uncontrolled asthma. N Engl J Med. 2017 Sep 7;377(10):936–946.
   PubMed Web of Science ®Google Scholar
• Heffler E, Guida G, Marsico P, et al. Exhaled nitric oxide as a diagnostic test for asthma in rhinitic patients with asthmatic symptoms. Respir Med. 2006 Nov;100(11):1981–1987.
   PubMed Web of Science ®Google Scholar
• Rolla G, Heffler E, Bommarito L, et al. Exhaled nitric oxide in persistent rhinitis with or without lower airway involvement: a review of the literature. J Breath Res. 2007 Dec;1(2):024003.
   PubMed Web of Science ®Google Scholar
• Guida G, Rolla G, Badiu I, et al. Determinants of exhaled nitric oxide in chronic rhinosinusitis. Chest. 2010 Mar;137(3):658–664.
   PubMed Web of Science ®Google Scholar
• Oh MJ, Lee JY, Lee BJ, et al. Exhaled nitric oxide measurement is useful for the exclusion of nonasthmatic eosinophilic bronchitis in patients with chronic cough. Chest. 2008 Nov;134(5):990–995.
   PubMed Web of Science ®Google Scholar
• Kharitonov SA, Yates DH, Barnes PJ. Inhaled glucocorticoids decrease nitric oxide in exhaled air of asthmatic patients. Am J Respir Crit Care Med. 1996 Jan;153(1):454–457.
   PubMed Web of Science ®Google Scholar
• Montuschi P, Mondino C, Koch P, et al. Effects of montelukast treatment and withdrawal on fractional exhaled nitric oxide and lung function in children with asthma. Chest. 2007 Dec;132(6):1876–1881.
   PubMed Web of Science ®Google Scholar
• van der Valk RJ, Baraldi E, Stern G, et al. Daily exhaled nitric oxide measurements and asthma exacerbations in children. Allergy. 2012 Feb;67(2):265–271.
   PubMed Web of Science ®Google Scholar
• McNicholl DM, Stevenson M, McGarvey LP, et al. The utility of fractional exhaled nitric oxide suppression in the identification of nonadherence in difficult asthma. Am J Respir Crit Care Med. 2012 Dec 1;186(11):1102–1108.
   PubMed Web of Science ®Google Scholar
• Aldakheel FM, Thomas PS, Bourke JE, et al. Relationships between adult asthma and oxidative stress markers and pH in exhaled breath condensate: a systematic review. Allergy. 2016 Jun;71(6):741–757.
   PubMed Web of Science ®Google Scholar
• Popov TA, Kralimarkova TZ, Labor M, et al. The added value of exhaled breath temperature in respiratory medicine. J Breath Res. 2017 Aug 8;11(3):034001.
   PubMed Web of Science ®Google Scholar
• Dragonieri S, Pennazza G, Carratu P, et al. Electronic nose technology in respiratory diseases. Lung. 2017 Apr;195(2):157–165.
   PubMed Web of Science ®Google Scholar
• Pavord ID, Sterk PJ, Hargreave FE, et al. Clinical applications of assessment of airway inflammation using induced sputum. Eur Respir J Suppl. 2002;37:40s–43s.
   PubMedGoogle Scholar
• de Vries R, Dagelet YWF, Spoor P, et al. Clinical and inflammatory phenotyping by breathomics in chronic airway diseases irrespective of the diagnostic label. Eur Respir J. 2018 Jan 11;51(1):pii: 1701817. .
   Web of Science ®Google Scholar
• Jia G, Erickson RW, Choy DF, et al. Bronchoscopic exploratory research study of biomarkers in corticosteroid-refractory asthma (BOBCAT) study group. periostin is a systemic biomarker of eosinophilic airway inflammation in asthmatic patients. J Allergy Clin Immunol. 2012 Sep;130(3):647–654.
   PubMed Web of Science ®Google Scholar
• Khatry DB, Gossage DL, Geba GP, et al. Discriminating sputum-eosinophilic asthma: accuracy of cutoffs in blood eosinophil measurements versus a composite index, ELEN. J Allergy Clin Immunol. 2015 Sep;136(3):812–814.
   PubMed Web of Science ®Google Scholar
• Heffler E, Terranova G, Chessari C, et al. Point-of-care blood eosinophil count in a severe asthma clinic setting. Ann Allergy Asthma Immunol. 2017;119:16–20.
   PubMed Web of Science ®Google Scholar
• Takai M, Ono J, Kamei A, et al. A novel, automated periostin assay; correlation with a commercial ELISA method and usability as an asthma biomarker [abstract]. Eur Respir J. 2016;48(suppl 60):OA1980.
   Google Scholar
• Steiss JO, Schmidt A, Rudloff S. Monitoring of omalizumab therapy by measuring free IgE using a bedside immunoassay. Clin Lab. 2015;61:31–37.
   PubMed Web of Science ®Google Scholar
• Agusti A, Bel E, Thomas M, et al. Treatable traits: toward precision medicine of chronic airway diseases. Eur Respir J. 2016 Feb;47(2):410–419.
   PubMed Web of Science ®Google Scholar
• Sokolowska M, Frei R, Lunjani N, et al. Microbiome and asthma. Asthma Res Pract. 2018;4:1.
   PubMedGoogle Scholar
• Loza MJ, Adcock I, Auffray C, et al. Longitudinally stable, clinically defined clusters of patients with asthma independently identified in the ADEPT and U-BIOPRED asthma studies. Ann Am Thorac Soc. 2016;3 Suppl 1:S102–3.
   Web of Science ®Google Scholar
• Qiu W, Guo F, Glass K, et al. Differential connectivity of gene regulatory networks distinguishes corticosteroid response in asthma. J Allergy Clin Immunol. 2018 Apr;141(4):1250–1258.
   PubMed Web of Science ®Google Scholar
• Shrimanker R, Choo XN, Pavord ID. A new approach to the classification and management of airways diseases: identification of treatable traits. Clin Sci (Lond). 2017 May 1;131(10):1027–1043.
   PubMed Web of Science ®Google Scholar
• König IR, Fuchs O, Hansen G, et al. What is precision medicine? Eur Respir J. 2017 Oct 19;50(4).
   PubMed Web of Science ®Google Scholar
• Agustí A, Bafadhel M, Beasley R, et al. on behalf of all participants in the seminar. Precision medicine in airway diseases: moving to clinical practice. Eur Respir J. 2017 Oct 19;50(4).
   Web of Science ®Google Scholar
• Pavord ID, Beasley R, Agusti A, et al. After asthma: redefining airways diseases. Lancet. 2018 Jan 27;391(10118):350–400.
   PubMed Web of Science ®Google Scholar
• McDonald VM, Higgins I, Wood LG, et al. Multidimensional assessment and tailored interventions for COPD: respiratory utopia or common sense? Thorax. 2013 Jul;68(7):691–694.
   PubMed Web of Science ®Google Scholar